Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tonix Pharmaceuticals Holding Corp.

NASDAQ: TNXP · Life Sciences · 7 alerts · CIK 1430306

Share price
$2.88Close, Nov 16
Market cap
$56M
Shares outstanding
19.43MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tonix Pharmaceuticals Holding Corp. filings on SEC EDGAR ↗

7:00 AM ET 8-K
Business Update

Tonix Pharmaceuticals Holding Business Update

Tonix Pharmaceuticals provided preliminary operating results for the third quarter ended September 30, 2026, estimating net revenue for TONMYA between $14.0 million and $15.0 million. The company also reported an estimated cash and cash equivalents balance of approximately $162.8 million as of quarter-end.

Term
Q3 2026
7:06 AM ET 8-K
Business Update

Tonix Pharmaceuticals Holding Business Update

Tonix Pharmaceuticals announced a new agreement with a major pharmacy benefit manager to provide coverage for TONMYA to approximately 21 million Medicare Part D beneficiaries. This expansion brings the total commercial and government payer coverage for the fibromyalgia treatment to approximately 166 million individuals, or 53% of the total U.S. population.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.